Molecular dimensions of the substrate binding site of cytochrome P-448.

The molecular geometries of specific substrates, inhibitors and inducers of cytochrome P-448 activity were determined using computer-graphic techniques for use in defining the molecular dimensions of the substrate binding site of this enzyme. Specific substrates of cytochrome P-448 are essentially planar molecules characterised by a small depth and a large area/depth ratio. In contrast, compounds that do not serve as substrates of cytochrome P-448 are bulky, non-planar molecules characterised by small area/depth ratios and greater flexibility in molecular conformation. Specific inhibitors of cytochrome P-448 whose effect is mediated through interaction with the haem still meet the dimensional criteria for substrates indicating that they must also interact with the substrate binding-site, which is probably located in proximity to the haem. Inducers of cytochrome P-448 activity exhibit similar molecular geometries to the substrates from which it may be inferred that the cytosolic receptor associated with the induction of cytochrome P-448 activity is structurally related to the active site of the cytochrome.

[1]  O. Gotoh,et al.  Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. , 1985, The Journal of biological chemistry.

[2]  A. Y. Lu,et al.  Aldrin epoxidation catalyzed by purified rat-liver cytochromes P-450 and P-448. High selectivity for cytochrome P-450. , 1980, European journal of biochemistry.

[3]  T. Kamataki,et al.  Metabolic activation of glutamic acid pyrolysis products, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole and 2-amino-dipyrido[1,2-a:3',2'-d]imidazole, by purified cytochrome P-450. , 1981, Chemico-biological interactions.

[4]  J. Vialle,et al.  THE CRYSTAL STRUCTURE OF MORPHINE HYDRATE , 1976 .

[5]  T. Kamataki,et al.  Metabolic activation of mutagenic tryptophan pyrolysis products (Trp-P-1 and Trp-P-2) by a purified cytochrome P-450-dependent monooxygenase system. , 1980, Cancer letters.

[6]  P. Thomas,et al.  Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  F. Guengerich,et al.  Selectivity of 1-phenylimidazole as a ligand for cytochrome P-450 and as an inhibitor of microsomal oxidation. , 1983, Biochemical pharmacology.

[8]  H. Yonekawa,et al.  Participation of the microsomal electron transport system in mutagenic activation of 4-dimethylaminoazobenzene, 4-methylaminoazobenzene and their 3'-methyl-derivatives. , 1982, Biochemical and biophysical research communications.

[9]  N. Harada,et al.  Purification and characterization of four forms of cytochrome P-450 from liver microsomes of phenobarbital-treated and 3-methylcholanthrene-treated rats. , 1984, Journal of biochemistry.

[10]  H. A. Masson,et al.  The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test. , 1983, Carcinogenesis.

[11]  Induction of different species of cytochrome P-450 by coplanar and noncoplanar isomers of hexachlorobiphenyl. , 1980, Life sciences.

[12]  T. Orton,et al.  Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). , 1982, The Biochemical journal.

[13]  C. Ioannides,et al.  Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to rats. , 1980, Chemico-biological interactions.

[14]  C. Ioannides,et al.  Foetal and neonatal development of cytochrome P-450 and cytochrome P-448 catalysed mixed function oxidases in the rat: induction by 3-methylcholanthrene. , 1985, Toxicology.

[15]  J. J. H. McDowell,et al.  The crystal and molecular structure of chlorpromazine , 1969 .

[16]  Michael J. S. Dewar,et al.  Ground states of molecules. XXV. MINDO/3. Improved version of the MINDO semiempirical SCF-MO method , 1975 .

[17]  T. Kamataki,et al.  Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver. , 1980, Cancer research.

[18]  A. J. Ryan,et al.  The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds. , 1983, Chemico-biological interactions.

[19]  W. Parsons,et al.  Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. , 1977, Life sciences.

[20]  P. Thomas,et al.  Use of monoclonal antibody probes against rat hepatic cytochromes P-450c and P-450d to detect immunochemically related isozymes in liver microsomes from different species. , 1984, Archives of biochemistry and biophysics.

[21]  M. Ingelman-Sundberg,et al.  Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. , 1984, The Journal of biological chemistry.

[22]  J. Leger,et al.  Structure cristalline du chlorhydrate de propranolol dextrogyre , 1975 .

[23]  P. Thomas,et al.  Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene. , 1979, The Journal of biological chemistry.

[24]  D. Parke Survey of drug-metabolizing enzymes. , 1983, Biochemical Society transactions.

[25]  A. Camerman,et al.  The stereochemical basis of anticonvulsant drug action. I. The crystal and molecular structure of diphenylhydantoin, a noncentrosymmetric structure solved by centric symbolic addition , 1971 .

[26]  K. Dus Insights into the active site of the cytochrome P-450 haemoprotein family--a unifying concept based on structural considerations. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[27]  Nebert Dw,et al.  The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. , 1979 .

[28]  D. Sutor The structures of the pyrimidines and purines. VI. The crystal structure of theophylline , 1958 .

[29]  A. Y. Lu,et al.  Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. II. Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. , 1972, The Journal of biological chemistry.

[30]  A. Conney,et al.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. , 1960, The Journal of pharmacology and experimental therapeutics.

[31]  M. Suzuki,et al.  Induction of hepatic microsomal propranolol N-desisopropylase activity by 3-methylcholanthrene and Sudan III. , 1982, Biochemical and biophysical research communications.

[32]  J. Hinson Reactive metabolites of phenacetin and acetaminophen: a review , 1983, Environmental health perspectives.

[33]  J. Bridges,et al.  Further studies on the dissociation of the isosafrole metabolite-cytochrome P-450 complex. , 1979, Biochemical pharmacology.

[34]  C. Ioannides,et al.  The mutagenicity of 9-hydroxyellipticine and its induction of cytochrome P-448 activity in rat liver microsomes. , 1982, Carcinogenesis.

[35]  F. Guengerich,et al.  Purification and characterization of the major microsomal cytochrome P-450 form induced by trans-stilbene oxide in rat liver. , 1984, Biochimica et biophysica acta.

[36]  C. Kennard,et al.  Insecticides. Part II. Crystal structures of 1,1-bis-(p-chlorophenyl)-2,2,2-trichloroethane (p,p′-DDT) and 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2,2-trichloroethane (o,p′-DDT) , 1972 .

[37]  D. Sutor The structures of the pyrimidines and purines. VII. The crystal structure of caffeine , 1958 .

[38]  C. Ioannides,et al.  Determination of cytochrome P-448 activity in biological tissues. , 1984, The Biochemical journal.

[39]  A. Y. Lu,et al.  Kinetic isotope effects on cytochrome P-450-catalyzed oxidation reactions. The oxidative O-dealkylation of 7-ethoxycoumarin. , 1984, The Journal of biological chemistry.

[40]  C. Lieber,et al.  NH2-terminal sequence analyses of four rat hepatic microsomal cytochromes P-450. , 1984, Archives of biochemistry and biophysics.

[41]  T. Inoue,et al.  The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) in vitro in rat. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.

[42]  H. L. Carrell,et al.  Molecular structures of 5,6- and 7,8-benzoflavones, inhibitors of aryl hydrocarbon hydroxylase. , 1980, Cancer research.

[43]  S. Scrimgeour,et al.  3,4‐Benzopyrene (a new refinement) , 1976 .

[44]  C. Ioannides,et al.  The role of nutrition in toxicology. , 1981, Annual review of nutrition.

[45]  C. Ioannides,et al.  Studies on the substrate-binding sites of liver microsomal cytochrome P-448. , 1982, The Biochemical journal.

[46]  F. Guengerich,et al.  Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. , 1984, Biochemistry.

[47]  Molecular structure of (±) 7α,8β-dihydroxy 9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; an X-ray crystallographic study , 1980 .

[48]  D. Nebert,et al.  Cytochrome P450 gene expression and regulation , 1985 .

[49]  J. Goldstein,et al.  Purification and characterization of a second form of hepatic cytochrome P-448 from rats treated with a pure polychlorinated biphenyl isomer. , 1982, The Journal of biological chemistry.

[50]  B. Craven Pseudosymmetry in cholesterol monohydrate , 1979 .

[51]  J. Depierre,et al.  Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. , 1985, Carcinogenesis.

[52]  A. Y. Lu,et al.  Role of Purified Cytochrome P-448 and Epoxide Hydrase in the Activation and Detoxification of Benzo[a]pyrene , 1977 .

[53]  C. Ioannides,et al.  Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448. , 1984, Chemico-biological interactions.

[54]  C. Ioannides,et al.  Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450. , 1981, Food and cosmetics toxicology.

[55]  F. Guengerich,et al.  Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. , 1984, Cancer research.

[56]  C. Ioannides,et al.  Cytochrome P-448 and the activation of toxic chemicals and carcinogens. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[57]  P. Thomas,et al.  Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. , 1983, The Journal of biological chemistry.

[58]  T. Cresteil,et al.  Enzymatic and immunological characterization of cytochromes P 450 from ellipticine-treated rat liver. , 1982, Biochemical and biophysical research communications.

[59]  P. Thomas,et al.  Purification and characterization of a minor form of hepatic microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls☆ , 1982 .

[60]  Eric F. Johnson,et al.  The role of cytochrome P-450 forms in 2-aminoanthracene and benz[α]pyrene mutagenesis , 1979 .

[61]  A. F. Peerdeman,et al.  The Crystal Structures of Aflatoxin B1. II. The Structure of an Orthorhombic and a Monoclinic Modification , 1970 .

[62]  C. Courseille,et al.  Structure cristalline et moléculaire de la quinacrine , 1973 .

[63]  F. Guengerich,et al.  Induction of cytochrome P-450 mRNAs quantitated by in vitro translation and immunoprecipitation. , 1984, Archives of biochemistry and biophysics.

[64]  S. Lohmann,et al.  Theophylline metabolism by the rat liver microsomal system. , 1976, The Journal of pharmacology and experimental therapeutics.

[65]  J. Cumps,et al.  Metyrapone - reduced cytochrome P-450 complex: a specific method for the determination of the phenobarbital inducible form of rat hepatic microsomal cytochrome P-450. , 1980, Biochemical and biophysical research communications.

[66]  H V Gelboin,et al.  Expression of cytochromes P-450 in rat hepatoma cells. Analysis by monoclonal antibodies specific for cytochromes P-450 from rat liver induced by 3-methylcholanthrene or phenobarbital. , 1984, European journal of biochemistry.

[67]  J. Maxwell,et al.  Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction? , 1972, British medical journal.

[68]  J. McDowell The Crystal and Molecular Structure of Phenothiazine , 1976 .